PSMA-PET Improves Prediction of Biochemical Recurrence in Prostate Cancer
MONDAY, July 31, 2023 (HealthDay News) -- Presurgical 68Ga-prostate-specific membrane antigen positron emission tomography (PSMA-PET) improves prediction of biochemical recurrence-free survival (BCR-FS) for patients with intermediate- to high-risk prostate cancer, according to a study published online July 21 in European Urology.
Loïc Djaïleb, M.D., Ph.D., from the David Geffen School of Medicine at the University of California Los Angeles, and colleagues conducted a follow-up study of a surgical cohort assessed in a prospective phase 3 imaging trial involving 277 patients with intermediate- to high-risk prostate cancer treated with radical prostatectomy and pelvic lymph node dissection. The added prognostic value of presurgical PSMA-PET for BCR-FS compared to the presurgical Cancer of the Prostate Risk Assessment (CAPRA) and postsurgical CAPRA-Surgery (CAPRA-S) scores was assessed.
Patients were followed for a median of 32.4 months after surgery; clinical follow-up was available for 240 patients. The researchers found that 91 of 240 BCR events were observed (38 percent). In 17 percent of patients, PSMA-PET extraprostatic disease (N1/M1) was found. Significant univariate predictors of BCR included PSMA-PET prostate uptake, PSMA-PET N1/M1, and CAPRA and CAPRA-S scores. The risk assessment for BCR was significantly improved with the addition of PSMA-PET N1/M1 status to the presurgical CAPRA score compared with the presurgical CAPRA score alone (C-statistic, 0.70 versus 0.63). There was no significant difference observed for the C-index of the postsurgical model utilizing the postsurgical CAPRA-S score alone from the presurgical model combining the presurgical CAPRA score and PSMA-PET N1/M1 status.
"In patients with prostate cancer considered for surgery, PSMA PET can provide information on the risk of recurrence after surgery, before the surgery even happens," Djaïleb said in a statement.
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Related Posts
¿Busca el amor este San Valentín? Deslizar tanto el dedo quizá no ayude
LUNES, 13 de febrero de 2023 (HealthDay News) -- Si usted es una de los millones...
Even Alligators Might Be Harmed by PFAS ‘Forever Chemicals’
THURSDAY, Oct. 20, 2022 (HealthDay News) -- Alligators along North Carolina's...
CPAP Helps Cut Heart Risks — But You Have to Actually Use It
WEDNESDAY, Oct. 4, 2023 (HealthDay News) -- For sufferers of sleep apnea,...